NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results